Mabwell logo white Mabwell Logo color
  • Science
  • Company
  • Press Releases
  • Careers
  • Contact us

Category: Press

Mabwell Receives IND Clearance from FDA for Initiating Clinical Trials for its Anti-CD47/PD-L1 Bispecific Antibody

Read More

NMPA Accepted IND Application of China’s First Anti-Nectin-4 ADC Drug

NMPA Accepted IND Application of China's First Anti-Nectin-4 ADC Drug
Read More

First China-made Anti-ST2 Antibody Developed by Mabwell Approved for Clinical Study

Read More

Mabwell participated in the Shanghai Biopharmaceutical Industry Innovation Alliance as the Secretary-General

Read More

Mabwell Closes Series A Financing of 1.97 Billion Yuan to Speed Up New Variety R&D and Industrialization

Read More

Mabwell Therapeutics, Inc. is a biotechnology company focusing on the discovery and development of antibody and protein-based drugs in multiple therapeutic areas including hematological disorders, liver disease, and neurodegenerative diseases.

Let Us Help You

  • Science
  • Company
  • Press Releases
  • Careers
  • Contact Us

Mabwell Therapeutics, Inc.

505 Coast Blvd S Ste 301
La Jolla, California
92037-4613
United States

(858) 352-6598

info@mabwell-therapeutics.com

Mabwell Logo color

Biotech Web Design Company © 2022 Mabwell Therapeutics, Inc.

All Rights Reserved.

  • Science
  • Company
  • Press Releases
  • Careers
  • Contact us

Thanks for applying!

We will get in touch with you shortly.